Donaueschingen (pta012/05.08.2021/08:30) - Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 17% and EBIT by approx. 20% in the first six months of 2021. As a result, the continually positive development of sales and earnings of the last years could be continued.
Sales improved from KEUR 77,659 to KEUR 90,857 (+17.0%) in the first half-year 2021. The international share of total business volume was 46.6% (6M 2020: 44.1%) and amounted to KEUR 42,320 compared to KEUR 34,267 (6M-2020).
The consolidated surplus rose very sharply by 22.2% to KEUR 7,580 (6M 2020: KEUR 6,201), and consolidated earnings before interest and taxes (EBIT) rose by 19.9% to KEUR 10,147 (6M 2020: KEUR 8,462): EBITA increased by 18.8% from KEUR 10,375 (6M-2020) to KEUR 12,329, and EBITDA increased by 10.4% to KEUR 18,391 (6M 2020: KEUR 16,663).
Operating cash flow increased by 3.8% to KEUR 27,070 in the first six months (6M-2020: KEUR 26,081) and remains at a very high level. As of 30/06/2021, the company had cash resources at its disposal in the amount of KEUR 29,553 (31/12/2020: KEUR 28,177). Nexus AG had equity capital amounting to KEUR 128,800 as of 30/06/2021 (31/12/2020: KEUR 123,583). Consequently, the equity capital rate is 50.9% (31/12/2020: 55.4%). This demonstrates that Nexus AG has a sustainable and healthy balance sheet as well as sufficient capital for further financing of its European growth strategy.
The Managing Board(end)
|contact person:||Hannes Wehinger|
|phone:||+49 771 22960-260|
|stock exchanges:||regulated market in Frankfurt, Hamburg; free market in Dusseldorf, free market in Munich, free market in Stuttgart; open market in Berlin|